Dynamic Advisor Solutions LLC Buys New Holdings in Globe Life Inc. $GL

Dynamic Advisor Solutions LLC bought a new position in Globe Life Inc. (NYSE:GL) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 6,700 shares of the company’s stock, valued at approximately $937,000.

A number of other institutional investors have also recently bought and sold shares of the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of Globe Life by 6.9% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,391 shares of the company’s stock valued at $1,237,000 after acquiring an additional 607 shares in the last quarter. NewEdge Advisors LLC boosted its stake in Globe Life by 368.1% in the 1st quarter. NewEdge Advisors LLC now owns 6,806 shares of the company’s stock valued at $897,000 after buying an additional 5,352 shares in the last quarter. Goldman Sachs Group Inc. boosted its stake in Globe Life by 11.5% in the 1st quarter. Goldman Sachs Group Inc. now owns 563,021 shares of the company’s stock valued at $74,161,000 after buying an additional 58,163 shares in the last quarter. Empowered Funds LLC bought a new stake in Globe Life in the first quarter valued at $428,000. Finally, Focus Partners Wealth grew its position in Globe Life by 8.3% in the first quarter. Focus Partners Wealth now owns 8,559 shares of the company’s stock valued at $1,127,000 after acquiring an additional 656 shares during the period. Institutional investors and hedge funds own 81.61% of the company’s stock.

Globe Life Trading Down 0.7%

GL stock opened at $137.56 on Thursday. The business has a fifty day moving average price of $141.54 and a 200 day moving average price of $138.89. Globe Life Inc. has a fifty-two week low of $109.38 and a fifty-two week high of $152.71. The stock has a market capitalization of $10.79 billion, a price-to-earnings ratio of 9.77 and a beta of 0.46. The company has a debt-to-equity ratio of 0.39, a current ratio of 0.07 and a quick ratio of 0.07.

Globe Life (NYSE:GL) last posted its quarterly earnings data on Wednesday, February 4th. The company reported $3.39 EPS for the quarter, missing analysts’ consensus estimates of $3.44 by ($0.05). The business had revenue of $1.52 billion during the quarter, compared to analyst estimates of $1.53 billion. Globe Life had a return on equity of 21.30% and a net margin of 19.37%.Globe Life’s revenue for the quarter was up 3.6% compared to the same quarter last year. During the same period in the prior year, the firm posted $3.14 EPS. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. Analysts expect that Globe Life Inc. will post 13.87 EPS for the current fiscal year.

Globe Life Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 1st. Investors of record on Friday, April 3rd will be issued a $0.33 dividend. This is a positive change from Globe Life’s previous quarterly dividend of $0.27. This represents a $1.32 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date of this dividend is Thursday, April 2nd. Globe Life’s dividend payout ratio (DPR) is presently 7.67%.

Analysts Set New Price Targets

A number of research analysts have issued reports on the company. TD Cowen reissued a “buy” rating on shares of Globe Life in a report on Thursday, December 11th. Truist Financial upped their target price on shares of Globe Life from $158.00 to $180.00 and gave the stock a “buy” rating in a report on Friday, February 6th. Wells Fargo & Company increased their target price on shares of Globe Life from $170.00 to $171.00 and gave the stock an “overweight” rating in a research report on Wednesday, February 25th. JPMorgan Chase & Co. lifted their price target on shares of Globe Life from $180.00 to $181.00 and gave the company an “overweight” rating in a report on Thursday, February 5th. Finally, Evercore set a $157.00 price target on shares of Globe Life in a research report on Wednesday, February 18th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat, Globe Life presently has an average rating of “Moderate Buy” and a consensus target price of $171.33.

Insider Buying and Selling at Globe Life

In other Globe Life news, CMO Jennifer Allison Haworth sold 10,000 shares of the firm’s stock in a transaction dated Thursday, February 12th. The shares were sold at an average price of $143.14, for a total value of $1,431,400.00. Following the completion of the sale, the chief marketing officer owned 17,479 shares in the company, valued at approximately $2,501,944.06. This trade represents a 36.39% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CEO Frank M. Svoboda sold 12,500 shares of the business’s stock in a transaction dated Tuesday, February 17th. The stock was sold at an average price of $144.78, for a total transaction of $1,809,750.00. Following the completion of the transaction, the chief executive officer directly owned 35,868 shares of the company’s stock, valued at approximately $5,192,969.04. This represents a 25.84% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 82,807 shares of company stock worth $12,041,286 over the last quarter. Corporate insiders own 1.51% of the company’s stock.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.